Woosok Lee

Woosok Lee

President & Chief Executive Officer

Woosok Lee, the President and CEO of TissueGene, brings a broad and multidisciplinary international experience to the company. In addition to his role at TissueGene, Mr. Lee currently serves as the President and CEO of Kolon Pharmaceuticals, Inc., the President and CEO of Kolon ePlatform, Inc., and the President and CEO of Kolon Life Science, Inc. Mr. Lee received his MBA from the UCLA University in Los Angeles, California, and his Bachelor's degree in Economics from the Seoul National University in Korea.

Bumsup Lee, Ph.D.

Bumsup Lee, Ph.D.

President & Chief Executive Officer

Bumsup Lee, D.V.M., Ph.D., President and CEO of TissueGene, joined TissueGene, Inc. as Chief Operating Officer. He was the Executive Vice President and CTO of Kolon Life Science, Inc (KLS), a position he held from May 2011 to May 2017, where he was responsible for a full range of R&D, clinical, business development, and manufacturing activities. Prior to joining KLS, he worked for biotechs and pharmaceutical companies such as Dong-A pharm, Mitokor, Syrrx, and Takeda San Diego. He has advanced multiple drug candidates through clinical development and won commercialization in the areas of diabetes, arthritis, and cancers. He obtained his D.V.M. and M.S. in pathology from Seoul National University and his Ph.D. from Iowa State University. He was a postdoctoral fellow at the State University of New York.

Soon-Wook Kweon

Soon-Wook Kweon

Chief Financial Officer

Soon-Wook Kweon joined TissueGene, Inc. in May, 2017 as the Chief Financial Officer. Before he joined TissueGene, he served as the Vice President of the Management & Finance Division in Kolon Corporation. He received his Bachelor of Arts in Economics at Korea University in Korea.

Jangik I. Lee, Ph.D.

Jangik I. Lee, Ph.D.

Outside Director

In addition to his role as the Outside Director at TissueGene, Jangik I. Lee also serves as the professor of Clinical Pharmacy and Regulatory Science in Seoul National University in Korea. He received his Ph.D. degree in the Clinical Pharmaceutical Scientist Program at the School of Pharmacy in University of Pittsburgh.

Young J. Kim, Ph.D.

Young J. Kim, Ph.D.

Statutory Auditor

Young J. Kim’s extensive experience in mission critical systems is well balanced with in-depth expertise in engineering & technology management and systems & software engineering. He founded and successfully led companies in the U.S. commercial and government service industries for many years. He received his Doctorate in Engineering Management at George Washington University.